Latest Supply Chain News

Little Green Pharma Ltd has reported a robust turnaround for FY2025, posting a $3.3 million profit after tax on revenues up 43%, driven by strong growth in Australia and Europe and strategic acquisitions.

Axel REE Limited announces a strategic leadership transition as it moves from exploration to development of its rare earth and gallium projects in Brazil, appointing new technical experts and seeking a new Managing Director to guide its next growth phase.

RareX Limited has partnered with Gega Elements to develop Australia’s inaugural integrated gallium supply chain, aiming to reduce reliance on Chinese supply and boost national critical mineral resilience.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Baumart Holdings has completed a modest capital raise through a rights issue, securing $182,303 before costs, with plans to issue additional shortfall shares to bolster its funding position.

HNG has consolidated its position in the school uniform sector by acquiring full ownership of Global Uniform Solutions and announcing a transformative acquisition of Trutex Group, setting the stage for significant growth across key markets.

Cobalt Blue Holdings has secured a pivotal three-year contract with Glencore to supply up to 50% of feedstock for its upcoming Kwinana Cobalt Refinery, marking a major step in advancing Australia's critical minerals ambitions.

TruScreen Group Limited has announced a capital raising initiative involving Placement and Share Purchase Plan (SPP) Options, aiming to secure approximately NZ$3 million to fund strategic growth and working capital needs. The offer, subject to shareholder approval, includes up to 80.9 million Placement Options and 55.5 million SPP Options exercisable at A$0.02.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Elsight Limited has expanded its supply agreement with a European defence drone OEM to a total of US$9.63 million for 2025, positioning the company for profitability and cash flow break-even this year.

The ACCC has raised preliminary concerns that Elders’ proposed acquisition of Delta Agribusiness could reduce competition in rural merchandise supply across key Australian regions, potentially impacting prices and service quality.

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.